BIOMAT Database Logo BIOMAT Database Logo

Intraventricular treatment of neonatal meningitis due to gram-negative bacilli. 1977

G H McCracken

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007232 Infant, Newborn, Diseases Diseases of newborn infants present at birth (congenital) or developing within the first month of birth. It does not include hereditary diseases not manifesting at birth or within the first 30 days of life nor does it include inborn errors of metabolism. Both HEREDITARY DISEASES and METABOLISM, INBORN ERRORS are available as general concepts. Neonatal Diseases,Disease, Neonatal,Diseases, Neonatal,Neonatal Disease
D007276 Injections, Intraventricular Injections into the cerebral ventricles. Intraventricular Injections,Injection, Intraventricular,Intraventricular Injection
D008581 Meningitis Inflammation of the coverings of the brain and/or spinal cord, which consist of the PIA MATER; ARACHNOID; and DURA MATER. Infections (viral, bacterial, and fungal) are the most common causes of this condition, but subarachnoid hemorrhage (HEMORRHAGES, SUBARACHNOID), chemical irritation (chemical MENINGITIS), granulomatous conditions, neoplastic conditions (CARCINOMATOUS MENINGITIS), and other inflammatory conditions may produce this syndrome. (From Joynt, Clinical Neurology, 1994, Ch24, p6) Pachymeningitis,Meningitides,Pachymeningitides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial

Related Publications

G H McCracken
Moxalactam (LY127935) in treatment of meningitis due to gram-negative bacilli.
February 1981, Antimicrobial agents and chemotherapy,
G H McCracken
[Bacterial meningitis due to gram-negative bacilli in adults].
April 2010, Revista de neurologia,
G H McCracken
[Treatment of pneumonia due to gram-negative bacilli].
May 1978, Nihon rinsho. Japanese journal of clinical medicine,
G H McCracken
The treatment of neonatal meningitis due to gram-negative bacilli with ciprofloxacin: evidence of satisfactory penetration into the cerebrospinal fluid.
May 1993, The Journal of infection,
G H McCracken
Septicaemia due to gram-negative bacilli.
March 1962, Lancet (London, England),
G H McCracken
Pneumonia due to gram-negative bacilli.
June 1960, Rhode Island medical journal,
G H McCracken
Bacteremia due to Gram-negative bacilli.
December 1966, Virginia medical monthly,
G H McCracken
Septicaemia due to gram-negative bacilli.
April 1955, Canadian Medical Association journal,
G H McCracken
[Meningitis caused by gram-negative bacilli].
September 1983, Medicina clinica,
G H McCracken
Meningitis caused by gram-negative bacilli.
August 1980, Annals of internal medicine,
Copied contents to your clipboard!